Ledger.Open graph →
SEC Form D · filed May 21, 2018

Emergo Therapeutics, Inc

Offering
$12.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Moise Khayrallah · Durham, NCExec · DirectorRobin Hyde-Deruyscher · Durham, NCExec · DirectorJennifer A. Lawton · Boulder, COExec · DirectorPaul A. Berberian · Boulder, COExec · DirectorAlex F. Knowles · Los Angeles, CAExec · DirectorFrederick M. Lax · Malibu, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗